Physician profile
Michael Brennan
NPI 1528280617
$127,706.24
in general payments reported to CMS, 2019-2025
8 companies · $38K in 2025
The $38K reported for 2025 was more than what 90% of Orthopaedic Trauma providers received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32K · 2020: $8,841 · 2021: $12K · 2022: $24K · 2023: $3,154 · 2024: $10K · 2025: $38K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $37K · Travel and Lodging: $13K · Food and Beverage: $1,783 · Education: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $36,900.00 |
| Travel and Lodging | $12,730.51 |
| Food and Beverage | $1,783.11 |
| Education | $120.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $126,843.49 | 2019-2025 | Gamma, Pangea, Hoffmann |
| Medical Device Business Services, INC. | $455.48 | 2019 | |
| Avanir Pharmaceuticals, INC. | $267.10 | 2019 | |
| Jazz Pharmaceuticals INC. | $44.93 | 2019 | |
| Vanda Pharmaceuticals INC. | $44.00 | 2019 | |
| Smith+Nephew, INC. | $21.83 | 2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Sun Pharmaceutical Industries INC. | $15.91 | 2020 | |
| Lundbeck LLC | $13.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Brennan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.